– Growing counterfeit cigarette manufacture and distribution leads to severe negative consequences for national credibility and regional economy
SEOUL, South Korea, June 2, 2025 /PRNewswire/ — KT&G, a global tobacco company, stated on the 2nd that it has taken civil legal action against local entities for manufacturing and distributing counterfeit products under its global superslim brand “ESSE.”
KT&G has recently confirmed that counterfeiters used aliases such as “KT&G India”, “KT&G Punjab”, and “KT&G Ambala” to illegally manufacture and distribute a significant volume of counterfeit cigarettes, appropriating the company’s global superslim brand “ESSE.”
To prevent counterfeiting activities, KT&G has taken legal action against local manufacturers and distributors across India, emphasizing that the company is unrelated to “KT&G India”, “KT&G Punjab”, and “KT&G Ambala” in any way.
Recently, the manufacture and distribution of counterfeit products under globally renowned brands are rapidly growing, gravely impacting national economy and regional societies. As the eradication of counterfeit tobacco becomes an urgent task, KT&G as well as other global tobacco manufacturers are heightening their responses.
Alongside legal actions, KT&G also plans an official brand launch in the Indian market on June 2nd. Any inquiries, including tips on counterfeit products or questions regarding official sale points or imports are handled by the local Indian partner, Kedara (e-mail: info@kedaratrading.com).
The manufacturer of the global brand ESSE, KT&G, is a well-known Korean company. It holds dominant positions in many markets, including the health functional foods market. It is also a global company that sells 870 brands across 148 countries as of 2024.
Logo – https://mma.prnewswire.com/media/2316472/KT_G_Logo.jpg
View original content:https://www.prnewswire.com/in/news-releases/ktg-takes-legal-action-against-local-counterfeit-cigarette-manufacturers-and-distributors-in-india-302470246.html
Kia PV5 Cargo earns the top five-star rating in the 2025 Euro NCAP Commercial Van…
New campaign highlights Kia’s commitment to promoting unity and connection for people around the worldKia…
In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine…
BENGALURU, India, Dec. 8, 2025 /PRNewswire/ -- Parkinson's disease often begins far more quietly than…
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction…
TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment…